CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Unraveling The Complexity Of Cell Therapy: Advancements And Challenges

  Cell therapy has emerged as a powerful tool for addressing critical medical challenges, but its rapid evolution necessitates a clear regulatory framework and consistent terminology.

• Laminar And Turbulent Mixing Techniques For LNP Formulations Scale Up

  Explore the critical factors in scaling up lipid nanoparticle (LNP) formulation, comparing the advantages and limitations of both laminar (microfluidic) and turbulent (tee and jet) mixing technologies.

• Monitoring Microbial Contamination Of Mammalian Cell Cultures

  Mammalian cells are widely used to produce complex processed molecules. Explore a system that effectively detects microbial contamination in mammalian cell cultures and utilizes a newly formulated lysis buffer.

• Confident Sialic Acid Identification With MS/MS

  Traditional mass spectrometry left uncertainty around potentially immunogenic glycans. Learn how a biologics developer achieved regulatory-ready clarity.

• End-To-End Workflow Integration For Antibody Development

  Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.

• Best Practices For Analysis Of In Vitro Transcribed (IVT) mRNA

  Learn best practices for high-resolution analysis of IVT RNA using automated capillary electrophoresis. Improve accuracy and precision in quantifying critical quality attributes.

• Commercial Success Starts With A Fit-For-Purpose Flow Cytometer

  Discover how standardizing reagents and automating flow cytometry workflows can improve reproducibility, reduce troubleshooting, and accelerate progress in cell-based therapies.

• Engineering Challenges In Designing Pharmaceutical Isolators

  Designing pharmaceutical barrier systems requires balancing strict cleanliness with practical engineering. Explore key factors for optimizing airflow and ergonomics.

• Synthetic DNA As An Alternative For Scalable Viral Vector Production

  Enzymatically synthesized DNA is assessed as a plasmid alternative, showing comparable viral vector yield, quality, and purification, while improving scalability and regulatory flexibility.

• Risk Assessment Services Align With FDA Guidance For Gene-Edited Human Gene Therapy Products

  Navigate the FDA's gene therapy guidelines with advanced risk assessment strategies. Optimize gene editing and ensure regulatory alignment for safer, more effective therapies.